OBJECTIVE: To determine whether a limited oxygen strategy (LOX) versus a high oxygen strategy (HOX) during delivery room resuscitation decreases oxidative stress in preterm neonates. METHODS: A randomized trial of neonates of 24 to 34 weeks' gestational age (GA) who received resuscitation was performed. LOX neonates received room air as the initial resuscitation gas, and fraction of inspired oxygen (Fio2) was adjusted by 10% every 30 seconds to achieve target preductal oxygen saturations (Spo2) as described by the 2010 Neonatal Resuscitation Program guidelines. HOX neonates received 100% O2 as initial resuscitation gas, and Fio2 was adjusted by 10% to keep preductal Spo2 at 85% to 94%. Total hydroperoxide (TH), biological antioxidant potential (BAP), and the oxidative balance ratio (BAP/TH) were analyzed in cord blood and the first hour of life. Secondary outcomes included delivery room interventions, respiratory support on NICU admission, and short-term morbidities. RESULTS:Forty-four LOX (GA: 30± 3 weeks; birth weight: 1678 ± 634 g) and 44 HOX (GA: 30 ± 3 weeks; birth weight: 1463 ±606 g) neonates were included. LOX decreased integrated excess oxygen (∑Fio2 × time [min]) in the delivery room compared with HOX (401 ± 151 vs 662 ± 249; P < .01). At 1 hour of life, BAP/TH was 60% higher for LOX versus HOX neonates (13 [9-16] vs 8 [6-9]) µM/U.CARR, P < .01). LOX decreased ventilator days (3 [0-64] vs 8 [0-96]; P < .05) and reduced the incidence of bronchopulmonary dysplasia (7% vs 25%; P < .05). CONCLUSIONS:LOX is feasible and results in less oxygen exposure, lower oxidative stress, and decreased respiratory morbidities and thus is a reasonable alternative for resuscitation of preterm neonates in the delivery room.
RCT Entities:
OBJECTIVE: To determine whether a limited oxygen strategy (LOX) versus a high oxygen strategy (HOX) during delivery room resuscitation decreases oxidative stress in preterm neonates. METHODS: A randomized trial of neonates of 24 to 34 weeks' gestational age (GA) who received resuscitation was performed. LOX neonates received room air as the initial resuscitation gas, and fraction of inspired oxygen (Fio2) was adjusted by 10% every 30 seconds to achieve target preductal oxygen saturations (Spo2) as described by the 2010 Neonatal Resuscitation Program guidelines. HOX neonates received 100% O2 as initial resuscitation gas, and Fio2 was adjusted by 10% to keep preductal Spo2 at 85% to 94%. Total hydroperoxide (TH), biological antioxidant potential (BAP), and the oxidative balance ratio (BAP/TH) were analyzed in cord blood and the first hour of life. Secondary outcomes included delivery room interventions, respiratory support on NICU admission, and short-term morbidities. RESULTS: Forty-four LOX (GA: 30 ± 3 weeks; birth weight: 1678 ± 634 g) and 44 HOX (GA: 30 ± 3 weeks; birth weight: 1463 ± 606 g) neonates were included. LOX decreased integrated excess oxygen (∑Fio2 × time [min]) in the delivery room compared with HOX (401 ± 151 vs 662 ± 249; P < .01). At 1 hour of life, BAP/TH was 60% higher for LOX versus HOX neonates (13 [9-16] vs 8 [6-9]) µM/U.CARR, P < .01). LOX decreased ventilator days (3 [0-64] vs 8 [0-96]; P < .05) and reduced the incidence of bronchopulmonary dysplasia (7% vs 25%; P < .05). CONCLUSIONS:LOX is feasible and results in less oxygen exposure, lower oxidative stress, and decreased respiratory morbidities and thus is a reasonable alternative for resuscitation of preterm neonates in the delivery room.
Authors: Wade D Rich; Kathy J Auten; Marie G Gantz; Ellen C Hale; Angelita M Hensman; Nancy S Newman; Neil N Finer Journal: Pediatrics Date: 2010-06-29 Impact factor: 7.124
Authors: Casey L Wang; Christina Anderson; Tina A Leone; Wade Rich; Balaji Govindaswami; Neil N Finer Journal: Pediatrics Date: 2008-06 Impact factor: 7.124
Authors: A Cavalleri; C Colombo; E Venturelli; R Miceli; L Mariani; U Cornelli; V Pala; F Berrino; G Secreto Journal: Int J Biol Markers Date: 2004 Jul-Sep Impact factor: 3.248
Authors: Vishal S Kapadia; Charitharth V Lal; Venkat Kakkilaya; Roy Heyne; Rashmin C Savani; Myra H Wyckoff Journal: J Pediatr Date: 2017-12 Impact factor: 4.406
Authors: Katherine C Wai; Michael A Kohn; Roberta A Ballard; William E Truog; Dennis M Black; Jeanette M Asselin; Philip L Ballard; Elizabeth E Rogers; Roberta L Keller Journal: J Pediatr Date: 2016-07-26 Impact factor: 4.406
Authors: Julia Kuligowski; Marta Aguar; Denise Rook; Isabel Lliso; Isabel Torres-Cuevas; Javier Escobar; Guillermo Quintás; María Brugada; Ángel Sánchez-Illana; Johannes B van Goudoever; Máximo Vento Journal: Antioxid Redox Signal Date: 2015-04-13 Impact factor: 8.401
Authors: Munmun Rawat; Praveen K Chandrasekharan; Daniel D Swartz; Bobby Mathew; Jayasree Nair; Sylvia F Gugino; Carmon Koenigsknecht; Payam Vali; Satyan Lakshminrusimha Journal: Pediatr Res Date: 2015-12-16 Impact factor: 3.756
Authors: Janneke Dekker; Anton H van Kaam; Charles C Roehr; Andreas W Flemmer; Elizabeth E Foglia; Stuart B Hooper; Arjan B Te Pas Journal: Pediatr Res Date: 2019-06-19 Impact factor: 3.756